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ABSTRACT 
 
The aim of this work was the cloning of those transmembrane glycoproteins G and F from an isolate 
bovine respiratory syncytial viruses (BRSV) – a Brazilian isolate of BRSV, named BRSV-25-BR in 
previous studies, in a prokaryotic system to proceed the sequencing of larger genomic fragments. The 
nucleotide substitutions were confirmed and these clones may also be used in further studies regarding 
the biological effects of those proteins in vitro and in vivo.  
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RESUMO 
 
O objetivo deste trabalho foi a clonagem das glicoproteínas transmembrana G e F de um isolado de vírus 
respiratório sincicial bovino (BRSV) - um isolado brasileiro denominado BRSV-25-BR- que já 
demonstrou possuir mutações em regiões altamente conservadas do gene da proteína G - em sistema 
procariótico, com o intuito de sequenciar fragmentos genômicos maiores. As substituições de 
nucleotídeos foram confirmadas e tais clones podem ser utilizados em futuros estudos sobre os efeitos 
biológicos destas proteínas tanto in vitro como in vivo.  
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INTRODUCTION 
 
Bovine respiratory syncytial virus (BRSV) was 
first isolated in 1967 (Paccaud and Jacquier, 
1970) from calves presenting respiratory distress. 
The distribution of BRSV is worldwide and it 
causes severe respiratory disease in young 
calves, characterized by bronchiolitis and 
interstitial pneumonia. BRSV is closely related 
to human respiratory syncytial virus (hRSV), 
which is a major cause of respiratory disease in 
young children, and the epidemiology and 
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pathogenesis of infection for these viruses are 
similar (Valarcher  and Taylor, 2007).  
 
The BRSV belongs to the genus  
Pneumovirus, subfamily Pneumovirinae, family    
Paramyxoviridae, Mononegavirales order 
(Vainionpää et al., 1989; Larsen, 2000; Easton et 
al., 2004). Members of the Mononegavirales 
order possess genomes constituted by a single 
strand of negative-sense RNA (3’→5’  
sense). The subfamily Pneumovirinae of 
Paramyxoviridae has two genera: the genus 
Pneumovirus contains bovine (RSV) as well as  
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human, caprine, and ovine RSVs and pneumonia 
virus of mice; the genus Metapneumovirus 
consists of avian metapneumovirus (aMPV) and 
human metapneumovirus (hMPV). The genus 
Metapneumovirus differs from the genus 
Pneumovirus on the absence of non-structural 
proteins NS1 and NS2, and in gene order for the 
F and M2 genes (Collins et al., 2001). 
 
The BRSV virion consists of a nucleocapsid 
contained within a lipid envelope. The envelope 
is a lipid bilayer that is derived from the host 
plasmatic membrane. It contains three virally 
encoded transmenbrane surface glycoproteins; 
the attachment protein (G), the fusion protein 
(F), and the small hydrophobic SH protein 
(Collins et al., 2001). 
 
The G protein was identified as the major 
attachment protein because antibodies specific to 
the G protein blocked the binding of the virus to 
cells (Levine et al., 1987), playing an important 
role in the immune response against BRSV 
infection (Bastien et al., 1997; Buchholz et al., 
2000; Spilki et al., 2006a). The G protein is a 
heavily glycosylated, type II membrane protein 
that does not share any sequence or structural 
homologies with attachment proteins of other 
paramyxoviruses (Wertz et al., 1985) and lacks  
haemaglutinating and neuraminidase activities 
(Easton et al., 2004). 
 
Glycoprotein G is composed of three domains: 
cytoplasmatic (AA 1-37) transmembrane (AA 
38-65) and extracellular ectodomain (AA 66-
257) (Langedijk et al., 1996). The cytoplasmatic 
domain is placed inside the viral envelope; the 
transmembrane domain runs across the 
cytoplasmatic membrane envelope. Both these 
sections of the protein are considerably 
conserved (Stine et al., 1997; Valentova, 2003). 
The extracellular domain of glycoprotein G is 
responsible for binding the virus to the sensitive 
cells, and the greatest differences within all viral 
proteins are localized there (Lerch et al., 1990). 
The ectodomain of the virus consists of 
hydrophobic variable regions and a central 
conserved region (Doreleijers et al., 1996; 
Langedijk et al., 1996). The variable regions of 
the protein are called mucin-like, due to their 
high content of carbohydrate side-chains 
bounded to Ser, Thr (O-linked sugars), and Pro 
(N-linked sugars). The central conserved region 
is the only relatively fixed and folded part of the 
ectodomain of RSV-G, containing four 
conserved cysteine residues which can form two 
disulphide bridges. It is speculated that this 
structure may interact with the host immune 
system, due to its similarity with fractalkines 
(Doreleijers et al., 1996; Langedijk et al., 1996). 
A Brazilian isolate has a major substitution of 
amino acids in this same region (Spilki et al., 
2006a), and studies using this peptide may be of 
interest to discover whether these features may 
induce differences in the biological effects of the 
protein in vivo. 
 
Experiments with mutant viruses possessing an 
induced deletion glycoprotein G coding gene 
showed that this glycoprotein is not necessary for 
virus replication in vitro, although its replication 
is considerably decreased in both cell cultures 
and the respiratory tract of mice. It also seems 
that glycoprotein G is not the only virus protein 
with attachment activity, but both the 
glycoproteins G and F play a role in attachment 
of the virus to cells (Karger et al., 2001; 
Techaarpornkul et al., 2001; Teng and Collins, 
2002). 
 
The F protein directs viral penetration through 
the fusion between the virion envelope and the 
host cell plasma membrane, delivering the 
nucleocapsid to the cytoplasm. Later in infection, 
the F protein expressed on the cell surface can 
mediate fusion with neighboring cells and form 
syncytia. This is a prominent cytophatic effect 
and is probably an additional mechanism of viral 
spread (Collins et al., 2001). The protein is 
synthesized primarily as the uncleaved precursor 
F0 that is cleaved by cellular proteases in the 
trans-Golgi network to yield the disulfide-linked 
heterodimer F2-F1 (Collins et al., 2001). The F 
protein induces neutralizing antibodies and 
confers resistance to BRSV infection (Taylor et 
al., 1992; Taylor et al., 1997; Thomas, et al., 
1998; Taylor et al., 2005). The F protein in 
BRSV is 574 AA in length (Lerch et al., 1990; 
Pastey et al., 1993) and is highly conserved 
between different BRSV isolates. 
  
The objectives of the present work were to clone 
the transmembrane glycoproteins G and F from a 
Brazilian BRSV isolate (antigenic subgroup B) 
in a prokaryotic system, to examine the 
nucleotide sequences on the conserved central 
region G and on particular sites of the F protein 
in BRSV, furthermore, to show mutations which 
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are located in the conserved central region G 
protein demonstrated in previous work and to 
examine whether there were mutations on the F 
protein gene.  
 
MATERIAL AND MEHTODS 
 
The Brazilian strain BRSV-25-BR (Arns et al., 
2003), was propagated in CRIB cells (Flores and 
Donis, 1995), a clone of MDBK cells resistant to 
the infection with BVDV, which is highly 
susceptible to the infection with BRSV (Flores 
and Donis, 1995; Spilki et al., 2006b). Cells were 
cultivated in Eagle’s minimal essential medium 
(E-MEM) supplemented with 10% of Fetal 
Bovine Serum, free of antibiotics following 
routine protocols, and titrated through the 
visualization of syncytia formation in an inverted 
microscope (Zeiss AxyovertTM, Oberkochen, 
Germany). 
 
RNA was extracted from infected CRIB cultures 
using High Pure Viral Nucleic extraction kitTM 
(Roche DiagnosticsTM, Manheim, Germany). 
cDNA was synthesized using SuperscriptIII 
FirstStrand Synthesis Super MixTM (Invitrogen 
Ltd., California, USA) following kit instructions 
for use with random hexamers. Primer 
oligonucleotides   were originally designed for 
the present work. PCR of BRSV genes were 
amplified using specific primers designed for the 
3’ and 5’ flanking regions of the G protein gene, 
which was the target for polymerase chain 
reaction. The forward primer BRSVG5 (5’ ATG 
TCC AAC CAT ACC CAC CAT CT 3’); the 
reverse primer BRSVG3 (5’ GGT GAA GAG 
AGG ATG CCT TG 3’) corresponding to 
amplified products of 752 bp. 
 
For the F protein gene the forward primer 
BRSVF5 (5’ ATA AGG ATG GCG ACA ACA 
GC 3’was used, annealing to the 3’ F protein 
gene flanking region); the reverse primer 
BRSVF3 (5’ AGG CCA GGC TTT GGT TTA 
TT 3’), near to the 5’ F protein gene flanking 
region, corresponds to amplified products of 
1538 bp. 
 
PCR was done in a 5μL  mixture containing 
2.5μL  of 10X PCR buffer (10mμ  Tris–HCl Ph 
8.0, 50 mμ KCl and 0.2mμ MgCl2), 1μL  of a 
10mμ dNTPs mixture, 10mμ of each primer, 
2.5mL of cDNA, and 0,2μL  (5U/μL ) of 
PlatinumTM High Fidelity DNA Polymerase 
(Invitrogen Ltd., California, USA). The 
amplification was pre-heated for 5min at 95ºC, 
following for 35 cycles, each of them composed 
of 1min at 94ºC (denaturation), 1min at 56ºC 
(annealing), and 1min at 72ºC (extension). After 
the completion of the 35 cycles, a final extension 
of 7min at 72ºC was performed.  Amplifications 
were carried out in a thermal cycler PCR System 
9700 (Gene Amp, Applied Biosystems, Perkin-
Elmer, California, USA). The PCR products 
were run on 1% agarose gel and visualized under 
UV light after being stained with ethidium 
bromide. 
 
The cloning of PCR product G and F genes was 
performed by using the plasmid vector 
pCR®8/GW/TOPO® TA Cloning® (Invitrogen 
Ltd., California, USA), procedures were 
performed according to the manufacturer’s 
instructions. 
 
The cloning reactions pTOPOG and pTOPOF, 
which transformed pCR®8/GW/TOPO® TA 
Cloning® construct into competent Escherichia 
coli DH5α (Clontech, Heidelberg, Germany), 
following the transform heat-shock. The bacterial 
colonies containing recombinant plasmids were 
selected in LB medium containing antibiotic 
spectinomycin (Sigma) and the plasmid DNA 
was extracted and purified using by Kit 
PureLink™ Quick Plasmid Miniprep Kit 
(Invitrogen Ltd., California, USA), according to 
the manufacturer’s instructions. The presence 
inserts pTOPOG and pTOPOF, were confirmed 
by PCR, following the protocol described. 
 
The confirmation of the identity and orientation 
inserts, the PCR products and pTOPOG and 
pTOPOF were sequenced using specific primers 
G and F genes and primers M13 vector were 
sequenced three times each, both in forward and 
reverse directions using ABI PRISM Big Dye 
Terminator Cycle Sequencing Ready Reaction 
kit (Applied BiosystemsTM). 
 
The BioEdit software, version 7.0.5.2 (Hall, 
1999), was used to manipulate the nucleotide 
sequences. Nucleotide alignments were 
performed using the Clustal W software, version 
1.83 (Thompson et al., 1994). Similarity to the 
PCR products and inserts with complete gene 
sequences are deposited in GenBank 
(http://www.ncbi.nlm.nih.gov/Genbank/index.ht
ml). The BRSV nucleotide sequences and 
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pTOPOG and pTOPOF nucleotide sequences 
obtained were submitted to the GenBank with 
access numbers FJ543090 and FJ543091. 
 
 
RESULTS AND DISCUSSION 
 
The obtained PCR products (Figure 1) were 
cloned into vector pTOPO generating pTOPOG 
and pTOPOF. The nucleotide sequences G and F 
genes were obtained through the partial 
sequencing of the plasmids pTOPOG and 
pTOPOF with primer M13. Obtained  
nucleotide sequences were compared with 
homolog sequences deposited at GenBank using 
the NCBI BLAST N program 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). The 
similarity sequences have demonstrated the 
higher degree homology 98% for G protein gene 
and 96% for F protein gene, thus confirming the 
identity of the target genomic inserts. 
 
Some differences were observed in the deduced 
amino acid level on the immunodominant region 
of the G gene. The two cysteins in positions 173 
and 176 of the amino acid sequence were 
replaced by alanine residues, and there were also 
other substitutions at this site: Ser174 was 
replaced by another alanine, Thr175 was 
substituted for a hystidine and Glu177, and Gly178 
was replaced by lysine and arginine residues, 
respectively (Spilki et al., 2006c). The amino 
acid changes were examined for putative 
structural changes on the central domain of the 
protein, and the result is that a major substitution 
occurred in the cystine-noose coding region of 
the Brazilian strain BRSV-25-BR of the G 
protein (Spilki et al., 2006c). 
 
The mutations described earlier for the G gene 
protein based on a smaller fragment which was 
sequenced directly from PCR products were now 
confirmed using plasmid-cloning based 
sequencing. No relevant mutations were found 
on the F protein gene. 
 
In this work the cloning and prokaryotic sistem 
was described for the transmembrane 
glycoproteins G and F of BRSV, wich are the 
main targets of immune response. The 
neutralizing antibodies are induced by G and F 
proteins, as evaluated in calves vaccinated with 
recombinant vaccinia viruses (rVV) encoding 
these proteins. The high titre of neutralizing 
antibodies are induced by F protein, but only a 
low level of complement-dependent neutralizing 
antibodies are induced by G protein (Taylor et 
al., 1997; Thomas et al., 1998). These antibodies 
provide predominantly strain-specific immunity, 
although recombinant vaccines which express 
only G protein BRSV are able to induce 
complete protective immunity of the lower and 
to a lesser extent upper respiratory tract 
(Shirijver et al., 1996; Taylor et al., 1998). 
 
The ability to manipulate the genome of BRSV 
may increase the understanding of the role of 
different proteins in the pathogenesis of this 
virus in calves and has provided opportunities for 
the development of stable, live attenuated virus 
vaccines, vector vaccines and DNA vaccines. 
Especially regarding the G protein of the isolate 
presently cloned, this may be useful to check 
whether particular features of this protein in such 
viral isolate may play a biological role or not, 
since previous work has shown that there is a 
major mutation between amino acid residues 173 
and 178, within the central hydrophobic 
conserved region, exactly on the site of two of 
the four cysteine-noose forming cysteine 
residues, which may interact with the cellular 
receptor (Valarcher et al., 2000) and plays an 
important role in the induction of antiviral host 
immunity (Langedijk et al., 1997). 
 
It may be speculated that the mutations presented 
by BRSV-25-BR G protein may have been 
induced by the presence of active and passive 
naturally acquired immune response against viral 
infection itself, and the virus may have been 
selected by infection animals processing 
antibodies to the virus, which selects antibody 
escape mutants, as demonstrated in vitro for 
hRSV (Martinez et al., 1997; Melero et al., 1997; 
Spilki et al., 2006c). 
 
Despite these alterations on the central 
hydrophobic region of the attachment protein, 
this virus infects calves efficiently under 
experimental conditions inducing moderate 
lesions on the lungs of infected animals 
(Almeida et al., 2005; Spilki et al., 2006c). 
 
An optimal BRSV vaccine would combine 
genetic stability, satisfactory growth in vitro, 
high attenuation in vivo and a satisfactory level 
of immunogenicity. Future studies with 
recombinant viruses represent a particularly 
Silva et al. 
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promising avenue for the development of 
vaccines and research, expressing antigens by 
virus vectors has proven to be a productive 
approach for studying in vitro and in vivo 
immune responses. An important feature of 
almost all recombinant viruses is the ability to 
induce not only humoral, but also cell-mediated 
immunity (Imler, 1995). Another possible use for 
the genes cloned on the present work may be as 
tools for the construction of recombinant vaccine 
candidates aiming BRSV immunization. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Bovine respiratory syncytial virus G 
and F gene amplification. RT-PCR was 
performed in RNA extracted from strain BRSV-
25-BR infected CRIB cells for G and F genes. 
1% agarose gel and visualized under UV light 
after being stained with ethidium bromide. A. 
1Kb DNA Ladder (Invitrogen Ltd., California, 
USA); B. strain BRSV-25BR G gene; C. 1Kb 
DNA Ladder (Invitrogen Ltd., California, USA); 
B – strain BRSV-25BR F gene and E. Reaction 
control.  
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